http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112708673-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
| filingDate | 2021-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112708673-B |
| titleOfInvention | Application of PRDM9 transposon fusion as congenital megacolon disease marker |
| abstract | The invention relates to the field of biomedicine, in particular to application of PRDM9 transposon fusion as a congenital megacolon disease marker. The fusion site of the PRDM9 transposon fusion is selected from PRDM9-type I located at chr5: 23299411; PRDM9-type II-1 at chr5: 23262356; and PRDM9-type II-2 at chr5: 23245181. Compared with the traditional diagnosis method (barium enema and the like), the method has the advantages of simple and quick operation, no intervention, high flux, low cost and the like. |
| priorityDate | 2021-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.